[1]JournalofChemicalResearch,2016,vol.40,#6,p.368-370
[2]Patent:WO2017/147542,2017,A2,.Locationinpatent:Paragraph00166
[3]Patent:CN107235848,2017,A,.Locationinpatent:Paragraph0021
[1]JournalofChemicalResearch,2016,vol.40,#6,p.368-370
[2]Patent:WO2017/147542,2017,A2,
[3]Patent:CN107235848,2017,A,
[1]JournalofChemicalResearch,2016,vol.40,#6,p.368-370
[2]Patent:WO2017/147542,2017,A2,
[3]Patent:CN107235848,2017,A,
[1]Patent:CN107235848,2017,A,
[1]BioconjugateChemistry,2018,vol.29,#4,p.1240-1250
[1]Patent:WO2011/39721,2011,A1
[1]Patent:WO2011/39721,2011,A1.Locationinpatent:Page/Pagecolumn21
[1]Patent:US2012/201828,2012,A1
[1]Patent:US2012/201828,2012,A1
[1]Patent:US2012/244172,2012,A1.Locationinpatent:Page/Pagecolumn32
Title: 99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression.
Journal: Molecular imaging 20111001
Title: Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.
Journal: Bioconjugate chemistry 20110817
Title: Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.
Journal: Theranostics 20110101
Title: Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability.
Journal: Theranostics 20110101
Title: Antibody-maytansinoid conjugates designed to bypass multidrug resistance.
Journal: Cancer research 20100315
Title: Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
Journal: Molecular imaging 20100201
Title: 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.
Journal: Bioconjugate chemistry 20090819
Title: Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
Journal: European journal of nuclear medicine and molecular imaging 20090801
Title: (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
Journal: European journal of nuclear medicine and molecular imaging 20090601
Title: Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers.
Journal: Bioconjugate chemistry 20090401
Title: Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
Journal: Molecular pharmaceutics 20090101
Title: DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.
Journal: European journal of nuclear medicine and molecular imaging 20070801
Title: Influence of different spacers on the biological profile of a DOTA-somatostatin analogue.
Journal: Bioconjugate chemistry 20070101
Title: Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer.
Journal: Bioconjugate chemistry 20060101
Title: Hans-Georg Lerchen, et al. Antibody drug conjugates (adcs) having enzymatically cleavable groups. WO2018114578A1.